SOURCE: Endexx Corporation

Endexx Corporation

August 14, 2013 09:54 ET

Endexx Brings M3hub™ to Washington State

Dispense Labs LLC. Licensed Vendor in Washington State

CAVE CREEK, AZ--(Marketwired - Aug 14, 2013) -  Endexx Corporation (OTC Pink: EDXC) Dispense Labs LLC. is now licensed to conduct business in the State of Washington as State registered Vendor. Dispense Labs LLC., the innovator and developer of Autospense™ dispense technologies is formally pursing a Washington State Liquor Control Board, Request for Proposal (RFP). This RFP is a prime use of the M3hub™ tracking, traceability and inventory control system offered by Dispense Labs. These systems are a core technology offering in the M3hub™ platform. The inventory control, tracking system, supply chain management, and security features provide a multi-point marijuana management platform. From seed to sale, the system fortifies the industry with a reliable and compliant, tracking and inventory control system. The software system operates in a secured network environment and cloud-based system with remote accessibility.

Joe DeRobbio, President of Dispense Labs, stated, "Dispense Labs is competing to win this State sponsored RFP against a limited group of other service providers. We are confident our systems meet all the requirements required in the RFP. This process provides us a unique opportunity to fully qualify and understand the direction of the marijuana market in Washington State and the needs of both regulators and licensees conducting business as growers, producers and retailers."

Todd Davis, CEO of Endexx, stated, "Endexx through Dispense Labs, is aggressively pursuing multiple domestic and international opportunities to establish the M3Hub™ technology platform as a standard in the medical and recreational management of marijuana in legalized markets. We have a solid and capable team ready to execute our business model."

About Endexx:

Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.

The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.

Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.

About Dispense Labs

Dispense Labs LLC., has spent several years investing in the research, design and development, and beta testing of Autospense™, a one-of-a-kind technologically driven smart system that allows for the automated dispensing of medical marijuana along with precise inventory control, utilizing predictive analytic algorithm and tracking software.

Autospense is a uniquely designed, high-tech automated dispensing system that exceeds industry standards. The software used is specifically designed to properly control transactions and manage inventory. This will significantly improve profitability, accountability, security tracking and customer satisfaction.

Contact: Todd Davis at 
Contact Endexx via email to receive corporate news and updates at,,

Safe Harbor Statement

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.

Contact Information